Annual Total Debt
$1.31 B
-$14.86 M-1.13%
31 December 2023
Summary:
Alnylam Pharmaceuticals annual total debt is currently $1.31 billion, with the most recent change of -$14.86 million (-1.13%) on 31 December 2023. During the last 3 years, it has risen by +$784.20 million (+150.46%). ALNY annual total debt is now -1.13% below its all-time high of $1.32 billion, reached on 31 December 2022.ALNY Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Debt
$1.30 B
-$1.87 M-0.14%
30 September 2024
Summary:
Alnylam Pharmaceuticals quarterly total debt is currently $1.30 billion, with the most recent change of -$1.87 million (-0.14%) on 30 September 2024. Over the past year, it has dropped by -$7.21 million (-0.55%). ALNY quarterly total debt is now -1.67% below its all-time high of $1.32 billion, reached on 30 September 2022.ALNY Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALNY Total Debt Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -1.1% | -0.6% |
3 y3 years | +150.5% | +71.2% |
5 y5 years | +4251.3% | +327.4% |
ALNY Total Debt High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -1.1% | +150.5% | -1.7% | +71.2% |
5 y | 5 years | -1.1% | +4251.3% | -1.7% | +328.5% |
alltime | all time | -1.1% | -1.7% |
Alnylam Pharmaceuticals Total Debt History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $1.30 B(-0.1%) |
June 2024 | - | $1.30 B(+0.2%) |
Mar 2024 | - | $1.30 B(-0.3%) |
Dec 2023 | $1.31 B(-1.1%) | $1.31 B(-0.3%) |
Sept 2023 | - | $1.31 B(-0.4%) |
June 2023 | - | $1.31 B(-0.5%) |
Mar 2023 | - | $1.32 B(+0.0%) |
Dec 2022 | $1.32 B(+32.3%) | $1.32 B(-0.3%) |
Sept 2022 | - | $1.32 B(+33.6%) |
June 2022 | - | $990.98 M(-0.4%) |
Mar 2022 | - | $995.39 M(-0.2%) |
Dec 2021 | $997.59 M(+91.4%) | $997.59 M(+31.2%) |
Sept 2021 | - | $760.44 M(-0.1%) |
June 2021 | - | $761.07 M(+46.8%) |
Mar 2021 | - | $518.52 M(-0.5%) |
Dec 2020 | $521.19 M(+71.5%) | $521.19 M(+58.2%) |
Sept 2020 | - | $329.45 M(+4.6%) |
June 2020 | - | $315.06 M(+3.4%) |
Mar 2020 | - | $304.82 M(+0.3%) |
Dec 2019 | $303.82 M(+912.7%) | $303.82 M(-0.3%) |
Sept 2019 | - | $304.62 M(-9.5%) |
June 2019 | - | $336.56 M(+2.2%) |
Mar 2019 | - | $329.28 M(+997.6%) |
Dec 2018 | $30.00 M(0.0%) | $30.00 M(0.0%) |
Sept 2018 | - | $30.00 M(0.0%) |
June 2018 | - | $30.00 M(0.0%) |
Mar 2018 | - | $30.00 M(0.0%) |
Dec 2017 | $30.00 M(-80.0%) | $30.00 M(-80.0%) |
Sept 2017 | - | $150.00 M(0.0%) |
June 2017 | - | $150.00 M(0.0%) |
Mar 2017 | - | $150.00 M(0.0%) |
Dec 2016 | $150.00 M(>+9900.0%) | $150.00 M(0.0%) |
Sept 2016 | - | $150.00 M(0.0%) |
June 2016 | - | $150.00 M(>+9900.0%) |
Mar 2016 | - | $0.00(0.0%) |
Dec 2015 | $0.00(0.0%) | $0.00(0.0%) |
Sept 2015 | - | $0.00(0.0%) |
June 2015 | - | $0.00(0.0%) |
Mar 2015 | - | $0.00(0.0%) |
Dec 2014 | $0.00(0.0%) | $0.00(0.0%) |
Sept 2014 | - | $0.00(0.0%) |
June 2014 | - | $0.00(0.0%) |
Mar 2014 | - | $0.00(0.0%) |
Dec 2013 | $0.00 | $0.00(0.0%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2013 | - | $0.00(0.0%) |
June 2013 | - | $0.00(0.0%) |
Mar 2013 | - | $0.00(0.0%) |
Dec 2012 | $0.00(0.0%) | $0.00(0.0%) |
Sept 2012 | - | $0.00(0.0%) |
June 2012 | - | $0.00(0.0%) |
Mar 2012 | - | $0.00(0.0%) |
Dec 2011 | $0.00(0.0%) | $0.00(0.0%) |
Sept 2011 | - | $0.00(0.0%) |
June 2011 | - | $0.00(0.0%) |
Mar 2011 | - | $0.00(0.0%) |
Dec 2010 | $0.00(0.0%) | $0.00(0.0%) |
Sept 2010 | - | $0.00(0.0%) |
June 2010 | - | $0.00(0.0%) |
Mar 2010 | - | $0.00(0.0%) |
Dec 2009 | $0.00(0.0%) | $0.00(0.0%) |
Sept 2009 | - | $0.00(0.0%) |
June 2009 | - | $0.00(0.0%) |
Mar 2009 | - | $0.00(0.0%) |
Dec 2008 | $0.00(-100.0%) | $0.00(-100.0%) |
Sept 2008 | - | $3.95 M(-19.6%) |
June 2008 | - | $4.91 M(-16.0%) |
Mar 2008 | - | $5.84 M(-13.5%) |
Dec 2007 | $6.76 M(-26.0%) | $6.76 M(-11.7%) |
Sept 2007 | - | $7.65 M(-10.2%) |
June 2007 | - | $8.52 M(+1.9%) |
Mar 2007 | - | $8.36 M(-8.5%) |
Dec 2006 | $9.14 M(+23.5%) | $9.14 M(-3.7%) |
Sept 2006 | - | $9.48 M(+4.7%) |
June 2006 | - | $9.05 M(+23.6%) |
Mar 2006 | - | $7.33 M(-0.9%) |
Dec 2005 | $7.39 M(+2.7%) | $7.39 M(-2.0%) |
Sept 2005 | - | $7.55 M(-5.2%) |
June 2005 | - | $7.96 M(+2.5%) |
Mar 2005 | - | $7.77 M(+7.8%) |
Dec 2004 | $7.20 M(+287.4%) | $7.20 M(+3.3%) |
Sept 2004 | - | $6.97 M(+22.2%) |
June 2004 | - | $5.71 M(+203.6%) |
Mar 2004 | - | $1.88 M(+1.1%) |
Dec 2003 | $1.86 M(>+9900.0%) | $1.86 M(>+9900.0%) |
Sept 2003 | - | $0.00(0.0%) |
June 2003 | - | $0.00(0.0%) |
Mar 2003 | - | $0.00 |
Dec 2002 | $0.00 | - |
FAQ
- What is Alnylam Pharmaceuticals annual total debt?
- What is the all time high annual total debt for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals annual total debt year-on-year change?
- What is Alnylam Pharmaceuticals quarterly total debt?
- What is the all time high quarterly total debt for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals quarterly total debt year-on-year change?
What is Alnylam Pharmaceuticals annual total debt?
The current annual total debt of ALNY is $1.31 B
What is the all time high annual total debt for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high annual total debt is $1.32 B
What is Alnylam Pharmaceuticals annual total debt year-on-year change?
Over the past year, ALNY annual total debt has changed by -$14.86 M (-1.13%)
What is Alnylam Pharmaceuticals quarterly total debt?
The current quarterly total debt of ALNY is $1.30 B
What is the all time high quarterly total debt for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high quarterly total debt is $1.32 B
What is Alnylam Pharmaceuticals quarterly total debt year-on-year change?
Over the past year, ALNY quarterly total debt has changed by -$7.21 M (-0.55%)